Exchange: NASDAQ·Updated 07:30 PM EDT
AKTS logo

AKTS Akoustis Technologies Inc

$26.77
$0.71
(2.73%)
Today
Closed $26.69
$0.08
(0.30%)
After Hours
Reported EarningsAug 13
Mkt Cap$1.44B
Vol601,241.00

About AKTS

Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
63

Bullish Sentiment

How do you feel about AKTS?

Advertisement|Remove ads.